| # | Drug | Count |
|---|---|---|
| 0 | ETOPOSIDE | 8 |
| 1 | CARBOPLATIN | 7 |
| 2 | IFOSFAMIDE | 7 |
| 3 | IFOSFAMIDE FOR INJECTION | 7 |
| 4 | DACTINOMYCIN | 6 |
| 5 | ADALIMUMAB | 5 |
| 6 | ADALIMUMAB-AATY | 4 |
| 7 | ADALIMUMAB-ADAZ | 4 |
| 8 | ADALIMUMAB-FKJP | 4 |
| 9 | VISMODEGIB | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DACTINOMYCIN | 6 | 0.0027 |
| 1 | VISMODEGIB | 3 | 0.0003 |
| 2 | IFOSFAMIDE FOR INJECTION | 7 | 0.0003 |
| 3 | ETOPOSIDE | 8 | 0.0001 |
| 4 | THIOTEPA | 1 | 0.0001 |
| 5 | ADALIMUMAB-FKJP | 4 | 0.0001 |
| 6 | ADALIMUMAB-AATY | 4 | 0.0001 |
| 7 | MECLIZINE HCL 12.5 MG | 1 | 0.0001 |
| 8 | ADALIMUMAB-ADAZ | 4 | 0.0001 |
| 9 | CARBOPLATIN | 7 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 8 |
| 1 | Topoisomerase Inhibitor [EPC] | 8 |
| 2 | Alkylating Drug [EPC] | 7 |
| 3 | Actinomycin [EPC] | 6 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 4 |
| 5 | Hedgehog Pathway Inhibitor [EPC] | 3 |
| 6 | Corticosteroid [EPC] | 2 |
| 7 | Interleukin-23 Antagonist [EPC] | 2 |
| 8 | Benzodiazepine [EPC] | 1 |
| 9 | Estrogen [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 6 | 0.0027 |
| 1 | Hedgehog Pathway Inhibitor [EPC] | 3 | 0.0003 |
| 2 | Topoisomerase Inhibitor [EPC] | 8 | 0.0001 |
| 3 | Platinum-based Drug [EPC] | 8 | 0.0000 |
| 4 | Alkylating Drug [EPC] | 7 | 0.0000 |
| 5 | Interleukin-23 Antagonist [EPC] | 2 | 0.0000 |
| 6 | Interleukin-12 Antagonist [EPC] | 1 | 0.0000 |
| 7 | Serotonin-3 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Janus Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Estrogen [EPC] | 1 | 0.0000 |